Effects of sub-chronic low-level lead exposure on the homeostasis of copper and zinc in rat tissues

Journal of Trace Elements in Medicine and Biology

Volumn 24, Issue 3, 2010, Pages 207-211

  Ademuyiwa, Oladipo ^a,b   Agarwal, Rakhi ^a   Chandra, Ramesh ^a   Raj Behari, Jai ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b FEDERAL UNIVERSITY OF AGRICULTURE   (Nigeria)

Author keywords

Copper and zinc metabolism; Imbalance; Sub chronic low level lead exposure

Indexed keywords

COPPER; DRINKING WATER; LEAD; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD; BODY REGIONS; BRAIN; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; DIETARY INTAKE; HEART; HOMEOSTASIS; KIDNEY; LEAD BLOOD LEVEL; LIVER; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; ZINC BLOOD LEVEL; ZINC METABOLISM;

ANIMALS; COPPER; ENVIRONMENTAL EXPOSURE; HOMEOSTASIS; LEAD; MALE; MICRONUTRIENTS; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; ZINC;

ANIMALIA; RATTUS;

EID: 77953539544     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2010.01.002     Document Type: Article

References (48)

1. Gilbert S.G., Weiss B. A rationale for lowering the blood lead action level from 10 to 2γg/dl. Neurotoxicology 2006, 27:693-701.
2. Park S.K., Schwartz J., Weisskopf M., Sparrow D., Vokonas P.S., Wright R.O., Coull B., Nie H., Hu H. Low-level lead exposure, metabolic syndrome, and heart rate variability: the VA normative aging study. Environ Health Perspect 2006, 114:1718-1724.
3. Ademuyiwa O., Ugbaja R.N., Rotimi S.O., Abam E., Okediran B.S., Dosumu O.A., Onunkwor B. Erythrocyte acetylcholinesterase activity as a surrogate indicator of lead-induced neurotoxicity in occupational lead exposure in Abeokuta, Nigeria. Environ Toxicol Pharmacol 2007, 24:183-188.
4. Spivey A. The weight of lead. Effects add up in adults. Environ Health Perspect 2007, 115(1):A31-A36.
5. Abam E., Okediran B.S., Odukoya O.O., Adamson I., Ademuyiwa O. Reversal of ionoregulatory disruptions in occupational lead exposure by vitamin C. Environ Toxicol Pharmacol 2008, 26(3):297-304.
6. Okediran B.S., Abam E., Odukoya O.O., Adamson I., Ademuyiwa O. Membrane, intracellular, plasma and urinary sodium and potassium in occupational lead exposure: effects of vitamin C supplementation. Trace Elem Electrolytes 2009, 20(2):49-59.
7. Basaran N., Undeger U. Effects of lead on immune parameters in occupationally exposed workers. Am J Ind Med 2000, 38:349-354.
8. Canfield R.L., Gendle M.H., Cory-Slechta D.A. Impaired neuropsychological functioning in lead-exposed children. Dev Neuropsychol 2004, 26(1):513-540.
9. Ademuyiwa O., Ugbaja R.N., Ojo D.A., Owoigbe A.O., Adeokun S.E. Reversal of aminolevulinic acid dehydratase (ALAD) inhibition and reduction of erythrocyte protoporphyrin levels by vitamin C in occupational lead exposure in Abeokuta, Nigeria. Environ Toxicol Pharmacol 2005, 20:404-411.
10. Sállmen M., Lindbohm M.L., Nurminen M. Paternal exposure to lead and infertility. Epidemiology 2000, 11:148-152.
11. Mahaffey K.R. Environmental lead toxicity: nutrition as a component of intervention. Environ Health Perspect 1990, 89:75-78.
12. Leggett R.W. An age-specific kinetic model of lead metabolism in humans. Environ Health Perspect 1993, 101:598-616.
13. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological profile for lead 2005, ATSDR, Atlanta, Georgia.
14. Muntner P., He J., Vupputuri S., Coresh J., Batuman V. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int 2003, 63:1044-1050.
15. Hu H., Aro A., Payton M., Korrick S., Sparrow D., Weiss S.T., Rotnitzky A. The relationship of bone and blood lead in hypertension-the normative aging study. JAMA 1996, 275:1171-1176.
16. Staessen J.A., Lauwerys R.R., Buchet J.P., Bulpitt C.J., Rondia D., Vanrenterghem Y., Amery A. Impairment of renal function with increasing blood lead concentrations in the general population. The cadmibel study group. N Eng J Med 1992, 327:151-156.
17. Payton M., Hu H., Sparrow D., Weiss S.T. Low-level lead exposure and renal function in the Normative aging study. Am J Epidemiol 1994, 140:821-829.
18. Lin J.L., Lin-Tan D.T., Hsu K.H., Yu C.C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Eng J Med 2003, 348:277-286.
19. Menke A., Muntner P., Batuman V., Silbergeld E.K., Guallar E. Blood lead below 0.48γmol/l (10γg/dL) and mortality among US adults. Circulation 2006, 114:1388-1394.
20. Petering H.G. Some observations on the interaction of zinc, copper, and iron metabolism in lead and cadmium toxicity. Environ Health Perspect 1978, 25:141-145.
21. Peraza M.A., Ayala-Fierro F., Barber D.S., Casarez E., Rael L.T. Effects of micronutrients on metal toxicity. Environ Health Perspect 1998, 106(Suppl. 1):203-216.
22. Marques M., Millás I., Jiménez A., Garcia-Colis E., Rodriguez-Feo J.A., Velasco S., Barrientos A., Casado S., López-Farre A. Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats. J Am Soc Nephrol 2001, 12:2594-2600.
23. Vaziri N.D., Ding Y., Ni Z. Compesatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 2001, 298(2):679-685.
24. Aungst B.J., Doice J.A., Fung H.-L. The effect of dose on the disposition of lead in rats after intravenous and oral administration. Toxicol Appl Pharmacol 1981, 61:48-57.
25. Sherlock J.C., Smart G., Forbes G.I., Moore M.R., Patterson W.J., Richards W.N., Wilson T.S. Assessment of lead intakes and dose-response for a population in Ayr exposed to a plumbo-solvent water supply. Hum Toxicol 1982, 1:115-122.
26. Pocock S.J., Shaper A.G., Walker M., Wale C.J., Clayton B., Delves T., Lacey R.F., Packham R.F., Powell P. Effects of tap water lead, water hardness, alcohol, and cigarettes on blood lead concentrations. J Epidemiol Community Health 1983, 37:1-7.
27. Sherlock J.C., Ashby D., Delves H.T., Forbes G.I., Moore M.R., Patterson W.J., Pocock S.J., Quinn M.J., Richards W.N., Wilson T.S. Reduction in exposure to lead from drinking water and its effect on blood lead concentrations. Hum Toxicol 1984, 3:383-392.
28. Sherlock J.C., Quinn M.J. Relationship between blood and lead concentrations and dietary lead intake in infants: the Glasgow duplicate diet study 1979-1980. Food Addit Contam 1986, 3:167-176.
29. Casteel W.S., Cowart R.P., Weis C.P., Hennigsen G.M., Hoffman E., Brattin W.J., Guzman R.E., Starost M.F., Payne J.T., Stockham S.L., Becker S.V., Drexler J.W., Turk J.R. Bio-availability of lead to juvenile swain dosed with soil from the Smuggler Mountain NLP site of Aspen, Colorado. Fundam Appl Toxicol 1997, 36:177-187.
30. 2+-sensing receptor is promiscuous divalent cation sensor that responds to lead. Am J Physiol Renal Physiol 2000, 279:F1083-F1091.
31. Quintanar-Escorza M.A., Gonzalez-Martínez M.T., Navarro L., Maldonado M., Arévalo B., Calderón-Salinas J.V. Intracellular free calcium concentration and calcium transport in human erythrocytes of lead-exposed workers. Toxicol Appl Pharmacol 2007, 220:1-8.
32. Qu W., Diwan B.A., Liu J., Goyer R.A., Dawson T., Horton J.L., Cherian M.G., Waalkes M.P. The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies. Am J Pathol 2002, 160(3):1047-1056.
33. Rhee S.J., Huang P.C. Metallothionein accumulation in CHO Cdr cells in response to lead treatment. Chem Biol Interact 1989, 72:347-361.
34. Maitani T., Watahiki A., Suzuki K.T. Induction of metallothionein after lead administration by three injection routes in mice. Toxicol Appl Pharmacol 1986, 83:211-217.
35. Ikebuchi H., Teshima B., Suzuki K., Terao T., Yamane Y. Simultaneous induction of lead-metallothionein-like protein and zinc-thionein in the liver of rats given lead acetate. Biochem J 1986, 233:541-546.
36. Goyer R.A., Clarkson T.W. Toxic effects of metals. Casarett and Doull's Essentials of Toxicology 2003, 348-359. McGraw-Hill Co., Inc., New York. C.D. Klaassen, J.B. Watkins (Eds.).
37. Mahoney J.P., Bush J.A., Gubler C.J., Moretz W.H., Cartwright G.E., Wintrobe M.M. Studies on copper metabolism XV. The excretion of copper by animals. J Lab Clin Med 1955, 46:702-708.
38. Goyer R.A. Toxic effects of metals. Casarett and Doull's Toxicology. The Basic Science of Poisons 1991, 623-680. Pergamon Press, New York. 4th ed. M.O. Amdour, J. Doull, C.D. Klaassen (Eds.).
39. Gregus Z., Varga F. Role of glutathione and hepatic glutathione-S-transferase in the biliary excretion of methylmercury, cadmium and zinc: a study with enzyme inducers and glutathione depletors. Acta Pharmacol Toxicol (Copenhagen) 1985, 56(5):398-403.
40. Smallwood R.A. Other liver diseases associated with increased liver copper concentration. Metals and the liver 1978, 313-330. Marcel Dekker, New York. L.W. Powell (Ed.).
41. Elsenhans B., Forth W., Richter E. Increased copper concentrations in rat tissues after acute intoxication with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol 1991, 65:429-432.
42. Banks E.G., Ferreti L.E., Shucard D.W. Effect of low level lead exposure on cognitive function in children: a review of behavioral, neurophysiological and biological evidence. Neurotoxicology 1997, 18(1):237-282.
43. Nehru B., Sidhu P. Behavior and neurotoxic consequences of lead on rat brain followed by recovery. Biol Trace Elem Res 2001, 84(1-3):113-121.
44. Canfield R.L., Henderson C.R., Cory-Slechta D.A., Cox C., Jusko T.A., Lanphear B.P. Intellectual impairment in children with blood lead concentrations below 10γg per deciliter. N Engl J Med 2003, 348(16):1517-1526.
45. Braun J.M., Froehlich T.E., Daniels J.L., Dietrich K.N., Hornung R., Auinger P., Lanphear B.P. Association of environmental toxicants and conduct disorder in U.S. children: NHANES 2001-2004. Environ Health Perspect 2008, 116(7):956-962.
46. Wright J.P., Dietrich K.N., Ris M.D., Hornung R.W., Wessel S.D., Lanphear B.P., Ho M., Rae M.N. Association of prenatal and childhood blood lead concentrations with criminal arrests in early childhood. PLoS Med 2008, 5(5):e101.
47. Walsh W.J., Isaacson H.R., Rehman F., Hall A. Elevated blood copper/zinc ratios in assaultive males. Physiol Behav 1997, 62:327-329.
48. Tokdemir M., Polat S.A., Acik Y., Gursu F., Cikim G., Deniz O. Blood zinc and copper concentrations in criminal and noncriminal schizophrenic men. J Androl 2003, 49:365-368.